 |
AX66488 |
(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-N-(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl)-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanamide |
2820046-26-0 |
C21H28F13NO11 |
717.4264 |
VIEW DETAILS > |
 |
AX66569 |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methyl(methyl-13C-d3)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
2378755-50-9 |
C37H64D3NO13 |
737.9379 |
VIEW DETAILS > |
 |
AX66769 |
thiazol-5-ylmethyl((2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-(morpholino-d8)butanamido)-1,6-diphenylhexan-2-yl)carbamate |
2699607-48-0 |
C40H45D8N7O5S2 |
784.072 |
VIEW DETAILS > |
 |
AZ93945 |
mPEG15-Br |
1567667-37-1 |
C31H63BrO15 |
755.7269200000004 |
VIEW DETAILS > |
 |
BG33642 |
Fmoc-Gly3-Val-Cit-PAB |
2647914-09-6 |
C39H48N8O9 |
772.8466 |
VIEW DETAILS > |
 |
BG42127 |
Clarithromycin-13C-d3 |
2699608-30-3 |
C38H66D3NO13 |
751.9645001720004 |
VIEW DETAILS > |
 |
BJ70403 |
N,N-Bis[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl]-4-(3-oxo-4-morpholinyl)aniline |
2097255-05-3 |
C40H34N8O10 |
786.7456 |
VIEW DETAILS > |
 |
BJ85416 |
Direct Black 38 |
1096153-86-4 |
C34H25N9Na2O7S2 |
781.7279 |
VIEW DETAILS > |
 |
BJ85788 |
6-BROMO-N-(2,4-DIFLUOROBENZYL)-4-((2,4-DIMETHOXYBENZYL)AMINO)-1-((3,4-DIMETHOXYBENZYL)OXY)-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE |
2448679-50-1 |
C34H31BrF2N4O7 |
725.5333 |
VIEW DETAILS > |
 |
BJ85885 |
Mesdopetam (hemitartrate) |
2562346-14-7 |
C28H42F2N2O12S2 |
700.7661 |
VIEW DETAILS > |